Literature DB >> 8064330

Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.

M N Romanelli1, S Dei, S Scapecchi, E Teodori, F Gualtieri, R Budriesi, R Mannhold.   

Abstract

In this work the rigid-analogue approach has been used to obtain information on the active conformation(s) of the calcium antagonist verapamil. A series of semi-rigid analogues of verapamil were synthesized and their biological activities evaluated on guinea-pig heart and aorta. These molecules were analysed by means of molecular modelling techniques. On the basis of the pharmacological profile and conformational analysis of these compounds, two different models for negative inotropic and negative chronotropic activity are proposed. The two actions seem to be due to conformations of the molecules which differ in the orientation of their phenylethylamino groups.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064330     DOI: 10.1007/bf00119863

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  15 in total

Review 1.  Classification and tissue selectivity of calcium antagonists.

Authors:  W G Nayler
Journal:  Z Kardiol       Date:  1990

2.  Comparative QSAR studies on vasodilatory and negative inotropic properties of ring-varied verapamil congeners.

Authors:  R Mannhold; R Bayer; M Ronsdorf; L Martens
Journal:  Arzneimittelforschung       Date:  1987-04

3.  Verapamil analogues with restricted molecular flexibility.

Authors:  S Dei; M N Romanelli; S Scapecchi; E Teodori; A Chiarini; F Gualtieri
Journal:  J Med Chem       Date:  1991-07       Impact factor: 7.446

4.  A search for calcium-channel activators in the verapamil series.

Authors:  M N Romanelli; F Gualtieri; R Mannhold; A Chiarini
Journal:  Farmaco       Date:  1989-05

5.  Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.

Authors:  C Bellucci; F Gualtieri; S Scapecchi; E Teodori; R Budriesi; A Chiarini
Journal:  Farmaco       Date:  1989-12

6.  Ionization and surface properties of verapamil and several verapamil analogues.

Authors:  G S Retzinger; L Cohen; S H Lau; F J Kézdy
Journal:  J Pharm Sci       Date:  1986-10       Impact factor: 3.534

7.  Evidence that uncharged verapamil inhibits myocardial contractility.

Authors:  L Cohen; D Vereault; J A Wasserstrom; G S Retzinger; F J Kezdy
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

8.  Verapamil analogues with restricted molecular flexibility: synthesis and pharmacological evaluation of the four isomers of alpha-[1-[3-[N-[1- [2-(3,4-dimethoxyphenyl)ethyl]]-N-methylamino]cyclohexyl]]-alpha- isopropyl-3,4-dimethoxybenzene-acetonitrile.

Authors:  S Dei; M N Romanelli; S Scapecchi; E Teodori; F Gualtieri; A Chiarini; W Voigt; H Lemoine
Journal:  J Med Chem       Date:  1993-02-19       Impact factor: 7.446

9.  6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.

Authors:  F I Carroll; P Abraham; K Parham; R C Griffith; A Ahmad; M M Richard; F N Padilla; J M Witkin; P K Chiang
Journal:  J Med Chem       Date:  1987-05       Impact factor: 7.446

10.  Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.

Authors:  J G Cannon; T Lee; H D Goldman
Journal:  J Med Chem       Date:  1977-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.